Why is Adline Chem Lab falling/rising?
As of 20-Jun, Adline Chem Lab Ltd's stock price is at 18.71, having increased by 1.96% over six days, with a strong annual return of 40.36%. However, the company has a negative book value and high debt-to-equity ratio, indicating it may be a risky investment despite recent performance.
As of 20-Jun, Adline Chem Lab Ltd's stock price is currently at 18.71, reflecting an increase of 0.36 or 1.96%. The stock has been on an upward trend, gaining for six consecutive days and achieving a total return of 11.77% during this period. It has outperformed its sector by 1.35% today and is trading above its moving averages across various time frames. Over the past year, the stock has delivered a strong return of 40.36%, significantly outperforming the BSE 500 index. However, despite these positive short-term performance indicators, the company faces challenges such as a negative book value and a high debt-to-equity ratio, which contribute to its classification as a risky investment.In the broader market context, Adline Chem Lab's recent performance has been notably strong, with a 9.61% increase over the past week compared to a 1.59% rise in the Sensex. This trend of outperformance extends to the one-month and three-year periods as well. However, while the stock has shown impressive short-term gains, it is important to note that its long-term fundamentals are weak, with net sales declining at an annual rate of -100% over the last five years. This juxtaposition of strong recent performance against a backdrop of poor long-term growth prospects may create a complex investment scenario for potential investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
